期刊文献+

尿液纤维连接蛋白糖链结构在膀胱癌患者中的变化及意义 被引量:1

Structural alterations and its significance of sugar chains in urine fibronectin from bladder cancer patients
原文传递
导出
摘要 目的寻求诊断膀胱癌的检测新方法。方法收集8例膀胱癌患者术前和术后3个月(正常)尿液标本16份,提纯纤维连接蛋白(Fn),辣根过氧化物酶(HRP)标记的凝集素作探针,连接到已固定在膜上的Fn糖链,检测已结合的HRP代表Fn糖链与凝集素的结合力,增强化学发光法(ECL)检测已结合HRP的结合力。高效液相(HPLC)和荧光标记底物测定膀胱癌和癌旁正常组织N-乙酰氨基葡萄糖转移酶(GnT)活力。结果用伴刀豆球蛋白凝集素(ConA)-HRP作探针时,膀胱癌尿液Fn结合力仅为正常膀胱尿液Fn的0.18,而用蔓陀罗凝集素(DSA)-HRP和麦胚凝集素(WGA)-HRP作探针时,膀胱癌组的结合力为正常组的3.34倍和3.26倍。膀胱癌患者尿液中FnN-糖链的天线数和平分型GlcNAc结构都升高。尿Fn与WGA的结合力与病理分期、分级相关。膀胱癌组织GnT-Ⅲ、Ⅳ和Ⅴ的酶活力比癌旁正常组织分别增加34.0、18.1和1.6倍。结论凝集素-HRP检测分析尿液Fn的N-糖链结构改变有可能是一种简单和精确诊断膀胱癌的方法。 Objective To investigate a new method for diagnosis of bladder cancer (BCa). Methods Sixteen urine samples from 8 patients with BCa preoperatively and 3 months postoperatively (proved to be normal) were collected, and the fibronectin (Fn) in the urine samples were purified. Different lectins labeled with horseradish peroxidase (HRP) were used as probes to bind the glycans of purified Fn immobilized on membrane. The enhanced chemiluminescence (ECL) reagent were adopted to estimate the activity of the bound HRP as a measure of the binding affinity of the Fn glycans to lectins, and expressed as luminescent light units (LLU). The enzymatic mechanism of the structural alteration of N-glycans in BCa Fn was studied with determination of GnT activities using HPLC method and fluorescent labeled substrate. Resuits The mean value of LLU of BCa Fn was only 18.1% of the normal samples when Con A-HRP was used as probes, while the mean LLU of BCa samples were 3.34 times and 3.26 times of the normal for the probes of DSA-HRP and WGA-HRP, respectively. These results revealed that the antennary number and bisecting GlcNAc structure were increased in the N-glycans of urine Fn from BCa, Besides, the binding affinity of Fn with WGA was correlated with pathological stage and grade, The results of GnT determination showed that GnT-Ⅲ, Ⅳ and Ⅴ in BCa tissues were increased by 34.0, 18.1 and 1.6 times respectively of the normal bladder tissues, Conclusions The lectin-HRP assay for analyzing the structure of N-glycans in urine Fn may be used as a simple and accurate diagnostic method for BCa in the future.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2005年第9期601-604,共4页 Chinese Journal of Urology
基金 吴阶平泌尿外科基金资助项目(962132)
关键词 膀胱肿瘤 尿液纤维连接蛋白 N-糖链 凝集素探针 糖基转移酶 纤维连接蛋白(Fn) 膀胱癌组织 尿液标本 糖链结构 癌患者 Bladder neoplasms Urine fibroneetin N-glyean Lectin probe binding assay Glycosyl-transferase
  • 相关文献

参考文献11

  • 1郭剑明,张永康,王国民,朱同玉,唐群业,邹秋锋.膀胱癌患者测定尿纤维连接蛋白的临床意义[J].中华泌尿外科杂志,1998,19(3):145-147. 被引量:7
  • 2郭剑明,张永康,孙宝荣,戎瑞明.Fn在膀胱癌组织中的分布及意义[J].中国临床医学杂志,2000,7(1):34-35. 被引量:5
  • 3Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem, 1970, 245:3059-3065.
  • 4陈惠黎.糖蛋白的聚糖[A].见:陈惠黎主编.生物大分子的结构和功能[M].上海:上海医科大学出版社,1999.331-367.
  • 5Zhang Y,Zhao JH,Zhang XY,et al. Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions. Mol Cell Biochem ,2004,260:137-146.
  • 6Guo P,Zhang Y,Shen ZH,et al. Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases. FEBS Lett, 2004,562:93-98.
  • 7Kim CH. Increased expression of N-acetylglucosaminyltransferase-V in human hepatoma cells by retinoic acid and 1alpha, 25-di hydroxyvitamin D3. Int J Biochem Cell Biol,2004,36:2307-2319.
  • 8Takamatsu S, Katsumata T, Inoue N, et al. Abnormal biantennary sugar chains are expressed in human chorionic gonadotropin produced in the choriocarcinoma cell line, JEG-3. Glycoconj J, 2004, 20:473 -481.
  • 9Malmstrom PU, Larsson A, Johansson S. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer. Br J Urol, 1993,72:307-310.
  • 10Osawa T,Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem, 1987,55:21-42.

二级参考文献8

  • 1[1]Skorstengard K, Thgersen HC, Petersen TE. Complete primary structure of the collagen binding domain of bovine fibronectin.Eur J Biochem, 1984, 140: 235-43.
  • 2[2]Pearlstein E, Gold LI, Angeles G. P., Fibronectin: A review of its structure and biological activity. Mol Cell Bioschem, 1980,29: 103.
  • 3[3]Grossman HB, Liebert M, Wedemeyer G, et al. Fibronectin distribution in normal and malignamt urothelium. J. Urol.1990, 143:418 - 420.
  • 4[4]Kuusela P, Ruoslahti E, Engvall E, et al. Immuochem, 1976,13: 639 - 642.
  • 5[5]Ratliff TL. Bacillus Calmette - Guerin (BCG) mechanism of action in superdical bladder cancer. Urology 1991, 37(5 suppl):8-11.
  • 6[6]Conn IG, Crocker J, Wallace DMA, et al. Basement membranes in urothelial carcinoma. Brit J Urol 1987, 60: 536.
  • 7[7]Labat- Robert J, Birembant P, Robert L, et al. Modification of fibronectin distribution pattern in solid human tumors. Diag.Histopathol, 1981, 4: 299.
  • 8[8]See WA, Xu Y, Gee K, et al. See WA, et al. Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines. (J Urol, 1997 Mar, 157: 3,1136-43).

共引文献16

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部